Asymmetric total synthesis of (+)-virosine A via sequential nucleophilic cyclizations onto an activated formamide

Journal of Organic Chemistry

Volumn 77, Issue 7, 2012, Pages 3215-3221

  Bélanger, Guillaume ^a   Dupuis, Marianne ^a   Larouche Gauthier, Robin ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ASYMMETRIC TOTAL SYNTHESIS; CYCLIZATIONS; FORMAMIDES; ONE POT;

AMIDES; METABOLITES; NITROGEN COMPOUNDS;

CYCLIZATION;

ALKALOID DERIVATIVE; FORMAMIDE; UNCLASSIFIED DRUG; VIROSINE A;

ARTICLE; CYCLIZATION; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOMER; MANNICH REACTION; VILSMEIER HAACK REACTION;

ALKALOIDS; CYCLIZATION; EUPHORBIACEAE; FORMAMIDES; HETEROCYCLIC COMPOUNDS WITH 4 OR MORE RINGS; MOLECULAR STRUCTURE; STEREOISOMERISM;

EID: 84859621930     PISSN: 00223263     EISSN: 15206904     Source Type: Journal    
DOI: 10.1021/jo202651t     Document Type: Article

References (21)

1. Snieckus, V. iIn The Alkaloids; Academic Press: New York, 1973; Vol. 14, pp 425-506.
2. Beutler, J. A.; Karbon, E. W.; Brubaker, A. N.; Malik, R.; Curtis, D. R.; Enna, S. J. Brain Res. 1985, 330, 135-140
3. Wang, G.-C.; Wang, Y.; Li, Q.; Liang, J.-P.; Zhang, X.-Q.; Yao, X.-S.; Ye, W.-C. Helv. Chim. Acta 2008, 91, 1124-1128. It should be noted that the structure of securinol A drawn in this article is erroneous: to be consistent with data and discussion in this article, the A ring should be a piperidine, not a pyrrolidine
4. Arbain, D.; Birkbeck, A. A.; Byrne, L. T.; Sargent, M. V.; Skelton, B. W.; White, A. H. J. Chem. Soc., Perkin Trans. 1 1991, 1863-1869
5. Horii, Z.; Ikeda, M.; Tamura, Y.; Saito, S.; Kotera, K.; Iwamoto, T. Chem. Pharm. Bull. 1965, 13, 1307-1311
6. The same initially proposed structures for securinol A and B by Horii (ref 5a) were mistakenly used again by Raj in 2008 (Raj, D.; Áuczkiewicz, M. Fitoterapia 2008, 79, 419-427), even though the structure had already been corrected by Arbain and Sargent in 1991 (ref 4)
7. Horii, Z.; Yamauchi, M.; Ikeda, M.; Momose, T. Chem. Pharm. Bull. 1970, 18, 2009-2012
8. Bélanger, G.; Larouche-Gauthier, R.; Ménard, F.; Nantel, M.; Barabé, F. Org. Lett. 2005, 7, 4431-4434
9. Bélanger, G.; Larouche-Gauthier, R.; Ménard, F.; Nantel, M.; Barabé, F. J. Org. Chem. 2006, 71, 704-712
10. Bélanger, G.; O'Brien, G.; Larouche-Gauthier, R. Org. Lett. 2011, 13, 4268-4271
11. Larouche-Gauthier, R.; Bélanger, G. Org. Lett. 2008, 10, 4501-4504
12. Mayr, H.; Kempf, B.; Ofial, A. R. Acc. Chem. Res. 2003, 36, 66-77
13. Katritzky, A. R.; Chang, H.-X.; Yang, B. Synthesis 1995, 503-505
14. Pasqua, A. E.; Matheson, M.; Sewell, A. L.; Marquez, R. Org. Process Res. Dev. 2011, 15, 467-470
15. Wu, M. H.; Jacobsen, E. N. Tetrahedron Lett. 1997, 38, 1693-1696
16. Anderson, A. G.; Stang, P. J. Org. Synth. 1981, 60, 34-39
17. Anderson, A. G.; Stang, P. J. J. Org. Chem. 1976, 41, 3034-3036
18. Deng, B.-L.; Hartman, T. L.; Buckheit, R. W.; Pannecouque, C.; De Clercq, E.; Fanwick, P. E.; Cushman, M. J. Med. Chem. 2005, 48, 6140-6155
19. Leighton, J. L.; Jacobsen, E. N. J. Org. Chem. 1996, 61, 389-390
20. Hill, G. J.; Rossiter, B. E.; Sharpless, K. B. J. Org. Chem. 1983, 48, 3607-3608
21. Ireland, R. E.; Liu, L. J. Org. Chem. 1993, 58, 2899-2899